Schaeffer Center researchers found that most hospital systems span across markets and states with higher system participation were more likely to have below median per capita hospital spending. Their work suggests that researchers and policymakers should consider hospital system membership separately from market concentration.
166 recently enacted prescription drug pricing laws were analyzed to identify those that contained price transparency measures. Of these, 35 bills in 22 states include a transparency component, but only 7 were deemed to be informative.
Value-based contracts must incentivize the clinical decision maker, usually the physician, to allocate treatment based on both price and value. Changing certain elements in the financing system could create an environment for successful value-based contracting without having to reform the entire system.
Successful auto-enrollment likely requires changes to the way we determine eligibility for Medicaid and Marketplace financial assistance, to make the system easier to navigate and more generous, writes USC-Brookings Schaeffer Initiative Fellow Christen Linke Young.
Schaeffer Initiative researchers explore why surprise out-of-network billing occurs and how federal and state governments can respond to eliminate these surprise bills and reduce inflated health care costs.
Researchers from the USC-Brookings Schaeffer Initiative for Health Policy discuss the negative effects of allowing firms to subsidize the purchase of individual market coverage and why the associated costs are likely to outweigh the benefits to employers and their workers.
Schaeffer Initiative experts describe the recent proposed rule by HHS that would loosen the rules governing Health Reimbursement Arrangements and its likely effects on insurance markets, employers, workers, and Marketplaces.